Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
biotech
boston
8
×
boston blog main
boston top stories
life science
8
×
life sciences
national blog main
national top stories
8
×
event
national
avapritinib
blueprint medicines
cancer
cancer drugs
capmatinib
eli lilly
europe blog main
europe top stories
gastrointestinal stromal tumors
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
roche
san francisco blog main
san francisco top stories
selpercatinib
thyroid cancer
What
accelerating
attend
biopharma's
biopharma’s
boston
breakthroughs
digital
future
health
learn
life
medical
registering
sciences
team
tech
xcelerating
join
online
address
approval
approves
bird
blueprint
cancer
carries
certain
designed
drug
early
ends
fda
genetic
latest
medicines
pass
ret
signature
signatures
targeted
Language
unset
Current search:
photo
×
boston
×
" national top stories "
×
" life science "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Join us this Wednesday for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health